Polku Therapeutics
Polku Therapeutics is a small molecule drugs manufacturer for neurodegenerative diseases founded in 2023 by Simon Bennett, Sebastian Soidinsalo, Timo Myöhänen and Docent Erik Wallén.
1
Funding Rounds
$2.3m
Money raised
Overview
Polku Therapeutics is a small molecule drugs manufacturer for neurodegenerative diseases founded in 2023 by Simon Bennett, Sebastian Soidinsalo, Timo Myöhänen and Docent Erik Wallén.
- Website:
- Business model: B2C
- Social accounts: linkedin
| Name | Phone | Social networks | |
|---|---|---|---|
| Ti** My******** |
|
- | - |
| Si*** Be***** |
|
- | - |
| Do**** Er** Wa***** | - | - | - |
| Se******* So******** |
|
- |
Funding series
Funding Series Analysis
The company Polku Therapeutics has raised a total of $2.3m in funding over 1 rounds.
Key Insights:
- Polku Therapeutics Pre-Seed Round, September 2024: $2.3m
Polku Therapeutics Pre-Seed Round, September 2024
$2.3m